መነሻ › የጡንቻ ካንሰር › Virginia › Norfolk
በNorfolk፣ VA ለየጡንቻ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለየጡንቻ ካንሰር የሚደረጉ 16 ጥናቶች በNorfolk እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
The Vanguard Study: Testing a New Way to Screen for Cancer
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
- Sentara Norfolk General Hospital, Norfolk
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Virginia Oncology Associates, Norfolk
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Virginia Oncology Associates, Norfolk
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- Sentara Norfolk General Hospital, Norfolk
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Virginia Oncology Associates, Norfolk
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Virginia Oncology Associates, Norfolk
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Virginia Oncology Associates (VOA) ( Site 8001), Norfolk
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Norfolk
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Virginia Oncology Associates (VOA) ( Site 8008), Norfolk
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Clinical Trial Site, Norfolk
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Virginia Oncology Associates (VOA) ( Site 8001), Norfolk
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Virginia Cancer Institute, Norfolk
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Virginia Oncology Associates (Norfolk) - USOR, Norfolk
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Virginia Oncology Associates, Norfolk
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- USOR Virginia Oncology Associates, Norfolk
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Virginia Oncology Associates, Norfolk
በሌሎች ከተሞች ለየጡንቻ ካንሰር የሚደረጉ ጥናቶች
- New York City, NY136 ጥናቶች
- Houston, TX126 ጥናቶች
- Boston, MA112 ጥናቶች
- Nashville, TN81 ጥናቶች
- Los Angeles, CA73 ጥናቶች
- Edison, NJ68 ጥናቶች
- St. Louis, MO64 ጥናቶች
- Queens, NY64 ጥናቶች
- Durham, NC64 ጥናቶች
- Chicago, IL59 ጥናቶች
- Philadelphia, PA56 ጥናቶች
- Dallas, TX55 ጥናቶች
በNorfolk ውስጥ ያሉ ሌሎች ጥናቶች
- የሽንት ፊኛ ካንሰር8 ጥናቶች
- የፕሮስቴት ካንሰር8 ጥናቶች
- የሆድ አውርታ አኒውሪዝም7 ጥናቶች
- የእንቁላል ካንሰር7 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር7 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)7 ጥናቶች
- የልብ ድካም7 ጥናቶች
- የልብና የደም ዝውውር ሕመም7 ጥናቶች
- የጋዜማ ገመድ ጡንቻ መኮማተር6 ጥናቶች
- ፔሪፈራል አርቴሪያል በሽታ5 ጥናቶች
- ትሪፕል-ኔጌቲቭ የደረት ካንሰር5 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ5 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።